Dr. Neal Shore presents the impressive updates for the results of the Aramis trial, examining Darolutamide for patients with non-metastatic castration-resistant prostate cancer.
The Uromigos Episode 80: Results for Darolutamide in Non-Metastatic CRPC—The Aramis Trial
By The Uromigos - Last Updated: February 13, 2021Post Tags:Uromigos-Prostate Cancer
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.